Loading insider details...
Beta
Latest Form 4 (Jul 27, 2026): Sale of 4,644 IRD shares, $13.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 27, 2026 | Opus Genetics, Inc. (IRD) | Sale | 4,644 | $13.7K |
| Apr 27, 2026 | Opus Genetics, Inc. (IRD) | Sale | 4,697 | $24.5K |
| Mar 18, 2026 | Opus Genetics, Inc. (IRD) | Sale | 3,719 | $19.5K |
| Jan 27, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 250,000 | n/a |
| Mar 18, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 52,500 | n/a |
| Mar 25, 2024 | Ocuphire Pharma, Inc. (OCUP) | Purchase | 2,000 | $4.1K |
| Nov 27, 2023 | Ocuphire Pharma, Inc. (OCUP) | Grant/Award | 300,000 | n/a |